CME Group reject nominating proxy; elects board

CME Group Inc. Announces Preliminary Results from its 2012 Annual Meeting of Shareholders

 

CME Group Inc. (NASDAQ: CME) today announced the preliminary shareholder voting results from its 2012 annual meeting.

At the meeting, shareholders:

  • Elected Dennis H. Chookaszian, Larry G. Gerdes, Daniel R. Glickman, James E. Oliff, Edemir Pinto, Alex J. Pollock and William R. Shepard each for a two-year term expiring in 2014;
  • Ratified the appointment of Ernst & Young as the company's independent registered public accounting firm for 2012;
  • Approved on an advisory basis the compensation of the company's named executive officers;
  • Approved the Fourth Amended and Restated Certificate of Incorporation of CME Group Inc. to eliminate the classification of the company's board as of the 2014 annual meeting;
  • Approved the CME Group Inc. Amended and Restated Omnibus Stock Plan; and
  • Approved the CME Group Inc. Amended and Restated Employee Stock Purchase Plan.

 

Shareholders did not approve the shareholder proposal to amend the company's By-Laws to allow shareholders to nominate director candidates for inclusion in the company's proxy materials.

In addition, the company's Class B-1 shareholders elected Jeffrey M. Bernacchi to a two-year term; Class B-2 shareholders elected David J. Wescott for a two-year term; and Class B-1 shareholders elected the members of its nominating committee. The election of the Class B-3 nominating committee was adjourned to June 13, 2012.

The official results and voting percentages for each of these proposals will be disclosed in a report to be filed early next week with the Securities and Exchange Commission.

Comments
comments powered by Disqus

eNewsletter Signup

Get the latest news and timely trading strategies for stock, options, forex, commodity, and financial derivatives markets with Futures' Daily Market Focus - FREE!